Alzheimer’s disease against peptides products of enzymatic cleavage of APP protein. Forming and variety of fibrillating peptides – some aspects

Various and different peptides products resulting from enzymatic protein cleavage of Amyloid Precursor Proteins (APP) are the main agents in the pathophysiology of Alzheimer’s disease (AD). Although relatively well-known, they still arouse interest leading to further intense and wide-ranging researc...

Full description

Bibliographic Details
Main Author: Małgorzata Marszałek
Format: Article
Language:English
Published: Index Copernicus International S.A. 2016-07-01
Series:Postępy Higieny i Medycyny Doświadczalnej
Subjects:
APP
Online Access:http://phmd.pl/gicid/01.3001.0009.6856
id doaj-c3297a4811294645b2cf98b02502d907
record_format Article
spelling doaj-c3297a4811294645b2cf98b02502d9072020-11-24T23:58:56ZengIndex Copernicus International S.A.Postępy Higieny i Medycyny Doświadczalnej0032-54491732-26932016-07-017078779610.5604/01.3001.0009.685601.3001.0009.6856Alzheimer’s disease against peptides products of enzymatic cleavage of APP protein. Forming and variety of fibrillating peptides – some aspectsMałgorzata Marszałek0Instytut Biofizyki, Uniwersytet ŁódzkiVarious and different peptides products resulting from enzymatic protein cleavage of Amyloid Precursor Proteins (APP) are the main agents in the pathophysiology of Alzheimer’s disease (AD). Although relatively well-known, they still arouse interest leading to further intense and wide-ranging research. Their biology and physico-chemical properties still are challenging for basic, experimental research and are matter of scientific debate. The APP itself and its functions are still somewhat enigmatic and therefore it is also called the All Purpose Protein. Apart from well known amyloidogenic and antiamyloidogenic (non-amyloidogenic) enzymatic cleavage pathways of APP protein this paper deals with issues connected with other, alternative pathways that seem to be interesting and important as well. They lead to other than Aβ forms of peptide products such as: N-APP, N-terminally cleavage products of APP (N-terminally truncated ) Aβ’, γ- secretase-independent pathway products that involve concerted cleavages of APP by α- and β-secretase or products that emerge after caspase activity. Presence of all these peptides in CSF, ISF, blood serum and urine of the AD patients is crucial for successful diagnosis, giving rise to hope of their better detection and potentially better treatment of AD. Therefore, newly discovered products of the AβT domain cleavage (Aβ total i.e. full fibrillating domain of APP), Aβ type products and other peptides because of their biology and physico-chemical properties are very intriguing and deserve further experimental research. On the other hand after better recognition and better understanding their biology they might be enormously useful in the future for diagnosis and therapy for example Alzheimer’s disease. http://phmd.pl/gicid/01.3001.0009.6856choroba alzheimerabiałko prekursorowe amyloiduAPPpeptyd Aβproces fibrylacjiAmyloid
collection DOAJ
language English
format Article
sources DOAJ
author Małgorzata Marszałek
spellingShingle Małgorzata Marszałek
Alzheimer’s disease against peptides products of enzymatic cleavage of APP protein. Forming and variety of fibrillating peptides – some aspects
Postępy Higieny i Medycyny Doświadczalnej
choroba alzheimera
białko prekursorowe amyloidu
APP
peptyd Aβ
proces fibrylacji
Amyloid
author_facet Małgorzata Marszałek
author_sort Małgorzata Marszałek
title Alzheimer’s disease against peptides products of enzymatic cleavage of APP protein. Forming and variety of fibrillating peptides – some aspects
title_short Alzheimer’s disease against peptides products of enzymatic cleavage of APP protein. Forming and variety of fibrillating peptides – some aspects
title_full Alzheimer’s disease against peptides products of enzymatic cleavage of APP protein. Forming and variety of fibrillating peptides – some aspects
title_fullStr Alzheimer’s disease against peptides products of enzymatic cleavage of APP protein. Forming and variety of fibrillating peptides – some aspects
title_full_unstemmed Alzheimer’s disease against peptides products of enzymatic cleavage of APP protein. Forming and variety of fibrillating peptides – some aspects
title_sort alzheimer’s disease against peptides products of enzymatic cleavage of app protein. forming and variety of fibrillating peptides – some aspects
publisher Index Copernicus International S.A.
series Postępy Higieny i Medycyny Doświadczalnej
issn 0032-5449
1732-2693
publishDate 2016-07-01
description Various and different peptides products resulting from enzymatic protein cleavage of Amyloid Precursor Proteins (APP) are the main agents in the pathophysiology of Alzheimer’s disease (AD). Although relatively well-known, they still arouse interest leading to further intense and wide-ranging research. Their biology and physico-chemical properties still are challenging for basic, experimental research and are matter of scientific debate. The APP itself and its functions are still somewhat enigmatic and therefore it is also called the All Purpose Protein. Apart from well known amyloidogenic and antiamyloidogenic (non-amyloidogenic) enzymatic cleavage pathways of APP protein this paper deals with issues connected with other, alternative pathways that seem to be interesting and important as well. They lead to other than Aβ forms of peptide products such as: N-APP, N-terminally cleavage products of APP (N-terminally truncated ) Aβ’, γ- secretase-independent pathway products that involve concerted cleavages of APP by α- and β-secretase or products that emerge after caspase activity. Presence of all these peptides in CSF, ISF, blood serum and urine of the AD patients is crucial for successful diagnosis, giving rise to hope of their better detection and potentially better treatment of AD. Therefore, newly discovered products of the AβT domain cleavage (Aβ total i.e. full fibrillating domain of APP), Aβ type products and other peptides because of their biology and physico-chemical properties are very intriguing and deserve further experimental research. On the other hand after better recognition and better understanding their biology they might be enormously useful in the future for diagnosis and therapy for example Alzheimer’s disease.
topic choroba alzheimera
białko prekursorowe amyloidu
APP
peptyd Aβ
proces fibrylacji
Amyloid
url http://phmd.pl/gicid/01.3001.0009.6856
work_keys_str_mv AT małgorzatamarszałek alzheimersdiseaseagainstpeptidesproductsofenzymaticcleavageofappproteinformingandvarietyoffibrillatingpeptidessomeaspects
_version_ 1725448889470812160